Contract medical device designer and manufacturer Creganna-Tactx Medical plans to open an office in a business incubator on Cleveland Clinic’s campus.
The Galway, Ireland-based company specializes in minimally invasive devices for a wide range of customers, including startups to the world’s leading medical device firms.
The focus of its Cleveland office will be preclinical research and development support, particularly in the area of atrial fibrillation, or irregular heartbeat, according to the company.
Creganna-Tractx’s Cleveland office will be in the Global Cardiovascular Innovation Center (GCIC), a $19 million, 50,000-square-foot building on Cleveland Clinic’s campus that opened last year. The goal of the Ohio Third Frontier-backed incubator is to house and feed fledgling companies that are developing products and services to diagnose or treat cardiovascular disease.
“Working with Cleveland Clinic’s GCIC, we can help bridge the gap between the designer and end-user physician in the development process,” Creganna-Tactx business development executive Randall Sword said in prepared remarks.
Creganna-Tactx in February announced a consulting partnership with Massachusetts and California-based contract research organization Boston Biomedical Associates. In addition to Ireland and the aforementioned states, Creganna-Tactx has operations in Minnesota, South Korea and Singapore. The company has about 1,000 employees worldwide.
A similar medical device outsourcing company, New Hampshire-based Farm, opened an office in the GCIC last year.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!